Biden administration poised to give pharmacies a major lobbying win
The Biden administration wants to rein in pharmacy fees charged by controversial drug middlemen in Medicare.
Read The StoryPolitics
Tracking how politics and policy influence health care and medicine. To get the latest delivered to your inbox, sign up for our free D.C. Diagnosis newsletter. And subscribe to STAT+ for inside intelligence on the intersection of Capitol Hill and the life sciences.
All Coverage
advertisement
